Prot #M23-698: A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Project: Research project

Project Details

StatusActive
Effective start/end date2/28/242/28/27

Funding

  • AbbVie Inc. (Prot #M23-698)